These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 23292080)

  • 1. Lipid-enveloped hybrid nanoparticles for drug delivery.
    Tan S; Li X; Guo Y; Zhang Z
    Nanoscale; 2013 Feb; 5(3):860-72. PubMed ID: 23292080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid nanocapsules: a new platform for nanomedicine.
    Huynh NT; Passirani C; Saulnier P; Benoit JP
    Int J Pharm; 2009 Sep; 379(2):201-9. PubMed ID: 19409468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The holistic 3M modality of drug delivery nanosystems for cancer therapy.
    Sun J; Luo C; Wang Y; He Z
    Nanoscale; 2013 Feb; 5(3):845-59. PubMed ID: 23292001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
    Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
    ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructured lipid carriers (NLCs) for drug delivery and targeting.
    Fang CL; Al-Suwayeh SA; Fang JY
    Recent Pat Nanotechnol; 2013 Jan; 7(1):41-55. PubMed ID: 22946628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
    Al-Jamal WT; Kostarelos K
    Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanostructured nanoparticles of self-assembled lipid pro-drugs as a route to improved chemotherapeutic agents.
    Sagnella SM; Gong X; Moghaddam MJ; Conn CE; Kimpton K; Waddington LJ; Krodkiewska I; Drummond CJ
    Nanoscale; 2011 Mar; 3(3):919-24. PubMed ID: 21173998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery of 10-hydroxycamptothecin to human breast cancers by cyclic RGD-modified lipid-polymer hybrid nanoparticles.
    Yang Z; Luo X; Zhang X; Liu J; Jiang Q
    Biomed Mater; 2013 Apr; 8(2):025012. PubMed ID: 23507576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current view on nanosized solid lipid carriers for drug delivery to the skin.
    Kristl J; Teskac K; Grabnar PA
    J Biomed Nanotechnol; 2010 Oct; 6(5):529-42. PubMed ID: 21329046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
    Pridgen EM; Langer R; Farokhzad OC
    Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid melittin cytolytic Peptide-driven ultrasmall lipid nanoparticles block melanoma growth in vivo.
    Huang C; Jin H; Qian Y; Qi S; Luo H; Luo Q; Zhang Z
    ACS Nano; 2013 Jul; 7(7):5791-800. PubMed ID: 23790040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanobiotechnology and its applications in drug delivery system: a review.
    Khan I; Khan M; Umar MN; Oh DH
    IET Nanobiotechnol; 2015 Dec; 9(6):396-400. PubMed ID: 26647817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanostructured lipid carriers: Promising drug delivery systems for future clinics.
    Beloqui A; Solinís MÁ; Rodríguez-Gascón A; Almeida AJ; Préat V
    Nanomedicine; 2016 Jan; 12(1):143-61. PubMed ID: 26410277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-core nanocapsules as a nanomedicine for parenteral administration of tretinoin: development and in vitro antitumor activity on human myeloid leukaemia cells.
    Ourique AF; Azoubel S; Ferreira CV; Silva CB; Marchiori MC; Pohlmann AR; Guterres SS; Beck RC
    J Biomed Nanotechnol; 2010 Jun; 6(3):214-23. PubMed ID: 21179938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine for the treatment of triple-negative breast cancer.
    Kutty RV; Wei Leong DT; Feng SS
    Nanomedicine (Lond); 2014 Apr; 9(5):561-4. PubMed ID: 24827837
    [No Abstract]   [Full Text] [Related]  

  • 18. Mesoporous silica nanoparticles: A multifunctional nano therapeutic system.
    Mai WX; Meng H
    Integr Biol (Camb); 2013 Jan; 5(1):19-28. PubMed ID: 23042147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimuli-responsive polymeric nanoparticles for nanomedicine.
    Crucho CI
    ChemMedChem; 2015 Jan; 10(1):24-38. PubMed ID: 25319803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.